SMTL ID : 8hts.1

Crystal structure of Bcl2 in complex with S-10r

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.25 Å

Oligo State

monomer

Ligands

1 x N2L: 4-[2-[(2~{S})-2-(2-cyclopropylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-~{N}-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1~{H}-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide(Non-covalent)

N2L.1: 17 residues within 4Å: Chain A: A.64, D.67, F.68, Y.72, D.75, F.76, M.79, N.107, W.108, G.109, R.110, V.112, A.113, F.117, F.162, Y.166, R.171 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:F.68, A:F.68, A:Y.72, A:D.75, A:F.76, A:F.76, A:R.110, A:V.112, A:F.117, A:Y.166 Hydrogen bonds: A:D.67, A:D.67, A:N.107, A:W.108, A:W.108, A:G.109, A:Y.166, A:R.171 pi-Stacking: A:Y.166

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Guo, Y. et al., Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl-2. J.Med.Chem. (2024)

Release Date

2024-05-15

Peptides

Apoptosis regulator Bcl-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Apoptosis regulator Bcl-2

Related Entries With Identical Sequence